Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population

Vaccine

Volumn 19, Issue 4-5, 2000, Pages 523-529

  Mossong, J ^a   O'Callaghan, C J ^a   Ratnam, S ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Newfoundland and Labrador Public Health Laboratory   (Canada)

Author keywords

Antibodies; Measles; Vaccination

Indexed keywords

MEASLES VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANADA; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; IMMUNIZATION SCHEDULE; LIKELIHOOD FUNCTIONS; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MODELS, BIOLOGICAL; SUPPORT, NON-U.S. GOV'T;

EID: 0034668181     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00175-4     Document Type: Article

References (8)

1. Christenson B., Bottiger M. Measles antibody - comparison of long-term vaccination titers, early vaccination titers and naturally acquired-immunity to and booster effects on the measles-virus. Vaccine. 12:1994;129-133.
2. Boulianne N., Deserres G., Ratnam S., Ward B.J., Joly J.R., Duval B. Measles, mumps, and rubella antibodies in children 5-6 years after immunization - effect of vaccine type and age at vaccination. Vaccine. 13:1995;1611-1616.
3. Davidkin I., Valle M. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts. Vaccine. 16:(20):1998;2052-2057.
4. Miller E., Hill A., Morgan-Capner P., Forsey T., Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine. 13:1995;799-802.
5. Moulton L.H., Halsey N.A. A mixed gamma model for regression analyses of quantitative assay data. Vaccine. 14:(12):1996;1154-1158.
6. Ratnam S., West R., Gadag V., Brett W., Oates E. Immunity against measles in school-aged children: implications for measles revaccination strategies. Can. J. Public Health. 87:(6):1996;407-410.
7. Chen R.T., Markowitz L.E., Albrecht P., et al. Measles antibody - reevaluation of protective titers. J. Infect. Dis. 162:1990;1036-1042.
8. Mossong J., Nokes D.J., Edmunds W.J., Cox M.J., Ratnam S., Muller C.P. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am. J. Epidemiol. 150:(11):1999;1238-1249.